Gyan E, Raynard B, Durand JP, Lacau Saint Guily J, Gouy S, Movschin ML et al (2018) Malnutrition in patients with cancer: comparison of perceptions by patients, relatives, and physicians-results of the NutriCancer2012 Study. JPEN J Parenter Enteral Nutr 42(1):255–60

Article  PubMed  Google Scholar 

Moses AW, Slater C, Preston T, Barber MD, Fearon KCH (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996–1002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69(4):491–7

Article  CAS  PubMed  Google Scholar 

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–95

Article  PubMed  Google Scholar 

Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C et al (2018) Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care. J Oncol Pract 14(4):e238–e250

Article  PubMed  PubMed Central  Google Scholar 

Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Dufour P et al (2014) Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus 27(6):560–567

Article  PubMed  Google Scholar 

Gupta D, Lammersfeld CA, Vashi PG, Dahlk SL, Lis CG (2008) Can subjective global assessment of nutritional status predict survival in ovarian cancer? J Ovarian Res 1(1):5

Article  PubMed  PubMed Central  Google Scholar 

Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T et al (2019) GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. Clin Nutr 38(1):1–9

Article  CAS  PubMed  Google Scholar 

Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L et al (2007) Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Reps 18(6):1521–7

CAS  Google Scholar 

Zhu R, Liu Z, Jiao R, Zhang C, Yu Q, Han S et al (2019) Updates on the pathogenesis of advanced lung cancer-induced cachexia. Thorac Cancer 10(1):8–16

Article  PubMed  Google Scholar 

McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR et al (2018) Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 19(3):310–322

Article  PubMed  PubMed Central  Google Scholar 

Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F et al (2019) A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable. J Immunother Cancer 7(1):57

Article  PubMed  PubMed Central  Google Scholar 

Alwarawrah Y, Kiernan K, MacIver NJ (2018) Changes in nutritional status impact immune cell metabolism and function. Front Immunol 9:1055

Article  PubMed  PubMed Central  Google Scholar 

Tanizaki J, Hayashi H, Kimura M, Tanaka K, Takeda M, Shimizu S et al (2016) Report of two cases of pseudoprogression in patients with non-small cell lung cancer treated with nivolumab-including histological analysis of one case after tumor regression. Lung Cancer 102:44–48

Article  PubMed  Google Scholar 

Okada S, Yamazaki S, Kaiga T, Funada T, Kochi M, Takayama T (2017) Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy. World J Surg Onc 15(1):162

Article  Google Scholar 

Mannion E, Gilmartin JJ, Donnellan P, Keane M, Waldron D (2014) Effect of chemotherapy on quality of life in patients with non-small cell lung cancer. Support Care Cancer 22(5):1417–1428

Article  PubMed  Google Scholar 

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48

Article  PubMed  Google Scholar 

Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG (2012) Role of nutritional status in predicting quality of life outcomes in cancer–a systematic review of the epidemiological literature. Nutr J 11:27

Article  PubMed  PubMed Central  Google Scholar 

Haute autorité de santé (2021) Diagnostic de la dénutrition chez l’enfant, l’adulte et la personne de 70 ans et plus. 

Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB (2014) Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nut 99(5):999–1005

Article  CAS  Google Scholar 

Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C et al (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33(1):90–9

Article  PubMed  Google Scholar 

Antoun S, Lanoy E, Ammari S, Farhane S, Martin L, Robert C et al (2023) Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle. Eur J Cancer 178:49–59

Article  PubMed  Google Scholar 

Roch B, Coffy A, Jean-Baptiste S, Palaysi E, Daures JP, Pujol JL et al (2020) Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors. Lung Cancer 143:19–26

Article  PubMed  Google Scholar 

Degens JHRJ, Dingemans AC, Willemsen ACH, Gietema HA, Hurkmans DP, Aerts JG et al (2021) The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab. J Cachexia Sarcopenia Muscle 12(3):657–664

Article  PubMed  PubMed Central  Google Scholar 

Darvin P, Toor SM, Sasidharan Nair V, Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50(12):1–11

Article  PubMed  Google Scholar 

Jørgensen JT (2016) Companion and complementary diagnostics: clinical and regulatory perspectives. Trends Cancer 2(12):706–712

Article  PubMed  Google Scholar 

Miyawaki T, Naito T, Kodama A, Nishioka N, Miyawaki E, Mamesaya N, et al. Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC. JTO Clinical and Research Reports [Internet]. 1 juin 2020 [cité 14 mai 2022];1(2). Disponible sur: https://www.jtocrr.org/article/S2666-3643(20)30020-5/fulltext

Takenaka Y, Oya R, Takemoto N, Inohara H (2021) Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis. J Cachexia Sarcopenia Muscle 12(5):1122–1135

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z, Pereira SL, Luo M, Matheson EM (2017) Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients 9(8):829

Article  PubMed  PubMed Central  Google Scholar 

Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH (2018) Cancer-associated cachexia. Nat Rev Dis Primers 4:17105

Article  PubMed  Google Scholar 

McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5):534–540

Article  PubMed  Google Scholar 

Abe A, Kurita K, Hayashi H, Ishihama T, Ueda A (2020) Correlation between prognostic nutritional index and occlusal status in gastric cancer. Oral Dis 26(2):465–472

Article  PubMed  Google Scholar